These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8292458)

  • 1. The synergistic effects of interleukin 2 and interleukin 7 on the proliferation and autologous tumor cell lysis of tumor-associated lymphocytes.
    Tsukuda M; Mochimatsu I; Sakumoto M; Mikami Y; Yuyama S; Yanoma S
    Biotherapy; 1993; 6(3):167-74. PubMed ID: 8292458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2.
    Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T
    Anticancer Res; 2001; 21(1B):669-77. PubMed ID: 11299824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomas.
    Tsukuda M; Mochimatsu I; Sakumoto M; Furukawa S; Yuyama S; Yanoma S; Kubota A
    Biotherapy; 1993; 6(2):155-61. PubMed ID: 8398575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
    Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
    J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.
    Hiraki A; Kiura K; Yamane H; Nogami N; Tabata M; Takigawa N; Ueoka H; Tanimoto M; Harada M
    Lung Cancer; 2002 Mar; 35(3):329-33. PubMed ID: 11844609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
    Wang P; Vánky F; Klein E
    Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.
    Grimm EA; Bruner JM; Carinhas J; Köppen JA; Loudon WG; Owen-Schaub L; Steck PA; Moser RP
    Cancer Immunol Immunother; 1991; 32(6):391-9. PubMed ID: 1848799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4.
    Lindgren CG; Thompson JA; Higuchi CM; Fefer A
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):322-8. PubMed ID: 8280715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of interleukin-2-activated lymphocytes for autologous normal blood mononuclear cells.
    Oshimi K; Oshimi Y; Saito H; Mizoguchi H
    J Immunol Methods; 1988 May; 109(2):161-8. PubMed ID: 3258896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
    Ioannides CG; Rashed S; Fisk B; Fan D; Itoh K; Freedman RS
    Lymphokine Cytokine Res; 1991 Aug; 10(4):307-15. PubMed ID: 1932375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of interleukin-12 on human tumor-infiltrating lymphocytes.
    Andrews JV; Schoof DD; Bertagnolli MM; Peoples GE; Goedegebuure PS; Eberlein TJ
    J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):1-10. PubMed ID: 8104476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor.
    Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tamai M; Arii K; Noguchi K
    Biotherapy; 1992; 4(1):9-15. PubMed ID: 1543654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
    Zhang YX; Wang XY; Liu JB; Zhang SQ; Chen YR
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):973-6. PubMed ID: 18756970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.
    Sica D; Rayman P; Stanley J; Edinger M; Tubbs RR; Klein E; Bukowski R; Finke JH
    Int J Cancer; 1993 Apr; 53(6):941-7. PubMed ID: 8473051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.
    Yoo YK; Heo DS; Hata K; Van Thiel DH; Whiteside TL
    Gastroenterology; 1990 Feb; 98(2):259-68. PubMed ID: 2295382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes.
    Mansfield PF; Salmeron MA; Rosenblum MG; Itoh K
    Int J Cancer; 1991 Sep; 49(3):356-61. PubMed ID: 1917133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro.
    Noguchi K; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Tani M; Mizobata S; Hotta T; Arii K; Tamai M
    Anticancer Res; 1995; 15(2):255-8. PubMed ID: 7762991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor).
    Gately MK; Desai BB; Wolitzky AG; Quinn PM; Dwyer CM; Podlaski FJ; Familletti PC; Sinigaglia F; Chizonnite R; Gubler U
    J Immunol; 1991 Aug; 147(3):874-82. PubMed ID: 1713608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.